Bisphenol A and Bisphenol S in Hemodialyzers

Bisphenol A (BPA)-based materials are used in the manufacturing of hemodialyzers, including their polycarbonate (PC) housings and polysulfone (PS) membranes. As concerns for BPA's adverse health effects rise, the regulation on BPA exposure is becoming more rigorous. Therefore, BPA alternatives, such as Bisphenol S (BPS), are increasingly used. It is important to understand the patient risk of BPA and BPS exposure through dialyzer use during hemodialysis. Here, we report the bisphenol levels in extractables and leachables obtained from eight dialyzers currently on the market, including high-flux and medium cut-off membranes. A targeted liquid chromatography-mass spectrometry strategy utilizing stable isotope-labeled internal standards provided reliable data for quantitation with the standard addition method. BPA ranging from 0.43 to 32.82 & mu;g/device and BPS ranging from 0.02 to 2.51 & mu;g/device were detected in dialyzers made with BPA- and BPS-containing materials, except for the novel FX CorAL 120 dialyzer. BPA and BPS were also not detected in bloodline controls and cellulose-based membranes. Based on the currently established tolerable intake (6 & mu;g/kg/day), the resulting margin of safety indicates that adverse effects are unlikely to occur in hemodialysis patients exposed to BPA and BPS quantified herein. With increasing availability of new data and information about the toxicity of BPA and BPS, the patient safety limits of BPA and BPS in those dialyzers may need a re-evaluation in the future.

Automated summary

This study reports the levels of bisphenol A (BPA) and bisphenol S (BPS) in eight different types of dialyzers currently on the market. BPA and BPS were detected in dialyzers made with BPA- and BPS-containing materials, except for one new type of dialyzer. Based on the established tolerable intake, the margin of safety suggests that adverse effects are unlikely to occur in hemodialysis patients exposed to BPA and BPS quantified in this study. However, the safety limits of BPA and BPS in these dialyzers may need to be re-evaluated in the future as more data and information about their toxicity become available.